Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2022-2025
Title: Tiago Rodrigues: Innovator in TRPV2 Antagonists
Introduction
Tiago Rodrigues is a prominent inventor based in Lisbon, Portugal. He has made significant contributions to the field of molecular medicine, particularly through his work on TRPV2 antagonists. With a total of 2 patents, Rodrigues has established himself as a key figure in innovative therapeutic solutions.
Latest Patents
Rodrigues' latest patents focus on the discovery of Piperlongumine compounds. These compounds, including Piperlongumine and its analogues, derivatives, and prodrugs, are identified as reversible, allosteric antagonists of the transient receptor potential vanilloid 2 channel (TRPV2). His inventions provide methods for treating conditions characterized by TRPV2 expression using these Piperlongumine compounds.
Career Highlights
Throughout his career, Tiago Rodrigues has worked with esteemed institutions such as the Instituto de Medicina Molecular João Lobo Antunes and the Gulbenkian Institute for Molecular Medicine. His research has contributed to advancements in understanding and treating various medical conditions.
Collaborations
Rodrigues has collaborated with notable professionals in his field, including João Conde and Charlotte Baker. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Tiago Rodrigues is a dedicated inventor whose work on TRPV2 antagonists has the potential to impact medical treatments significantly. His contributions to molecular medicine highlight the importance of innovation in addressing health challenges.